ASX - By Stock
|
NEU |
Re:
FDA
|
|
megamutts
|
122 |
47K |
10 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
122
|
47K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
14 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
16 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
a current prediction
|
|
megamutts
|
128 |
771K |
3 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
128
|
771K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
14 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
14
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
megamutts
|
1.5K |
649K |
18 |
19/02/23 |
19/02/23 |
ASX - By Stock
|
1.5K
|
649K
|
18
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
megamutts
|
10K |
4.9M |
14 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
10K
|
4.9M
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
megamutts
|
1.1K |
587K |
27 |
29/01/23 |
29/01/23 |
ASX - By Stock
|
1.1K
|
587K
|
27
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
megamutts
|
1.5K |
649K |
13 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
1.5K
|
649K
|
13
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
megamutts
|
515 |
237K |
15 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
515
|
237K
|
15
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
megamutts
|
515 |
237K |
10 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
515
|
237K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
megamutts
|
3.2K |
1.2M |
14 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
3.2K
|
1.2M
|
14
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
megamutts
|
3.2K |
1.2M |
15 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
3.2K
|
1.2M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
9 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
2.7K
|
1.1M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
JPMorgan conference
|
|
megamutts
|
18 |
11K |
10 |
11/01/23 |
11/01/23 |
ASX - By Stock
|
18
|
11K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
JPMorgan conference
|
|
megamutts
|
18 |
11K |
2 |
10/01/23 |
10/01/23 |
ASX - By Stock
|
18
|
11K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-003 trial 50% enrolment milestone has been achieved
|
|
megamutts
|
8 |
6.4K |
22 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
8
|
6.4K
|
22
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Update on MBC trial design following successful FDA meeting
|
|
megamutts
|
22 |
12K |
19 |
23/12/22 |
23/12/22 |
ASX - By Stock
|
22
|
12K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
9 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
382
|
194K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
9 |
11/12/22 |
11/12/22 |
ASX - By Stock
|
382
|
194K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
10 |
03/12/22 |
03/12/22 |
ASX - By Stock
|
382
|
194K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
megamutts
|
1.5K |
649K |
4 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
1.5K
|
649K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
0 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
382
|
194K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: TACTI-002 data presented at SITC for Efti in 1st line NSCLC
|
|
megamutts
|
11 |
7.3K |
13 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
11
|
7.3K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
1 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
382
|
194K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
megamutts
|
1.1K |
587K |
9 |
10/11/22 |
10/11/22 |
ASX - By Stock
|
1.1K
|
587K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
0 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
382
|
194K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
2 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
15 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Abstract for Efti selected for SITC 2022 Press Conference
|
|
megamutts
|
20 |
9.6K |
15 |
06/11/22 |
06/11/22 |
ASX - By Stock
|
20
|
9.6K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Independent DMC recommends to continue TACTI-003 as planned
|
|
megamutts
|
17 |
9.5K |
5 |
30/10/22 |
30/10/22 |
ASX - By Stock
|
17
|
9.5K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
megamutts
|
2 |
1.3K |
7 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
2
|
1.3K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
2 |
22/10/22 |
22/10/22 |
ASX - By Stock
|
382
|
194K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
5 |
22/10/22 |
22/10/22 |
ASX - By Stock
|
382
|
194K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
3 |
14/10/22 |
14/10/22 |
ASX - By Stock
|
382
|
194K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: SPP Results and Placement
|
|
megamutts
|
50 |
20K |
4 |
13/10/22 |
13/10/22 |
ASX - By Stock
|
50
|
20K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
8 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Abstracts accepted for Presentation at SITC 2022
|
|
megamutts
|
7 |
3.9K |
8 |
06/10/22 |
06/10/22 |
ASX - By Stock
|
7
|
3.9K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
3 |
29/09/22 |
29/09/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to Participate in Two Upcoming Investor Conferences
|
|
megamutts
|
5 |
3.0K |
2 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
5
|
3.0K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Possible New Cancer Treatment
|
|
megamutts
|
4 |
2.4K |
3 |
25/09/22 |
25/09/22 |
ASX - By Stock
|
4
|
2.4K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Receives A$2.7 million R&D French Tax Incentive
|
|
megamutts
|
1 |
999 |
8 |
24/09/22 |
24/09/22 |
ASX - By Stock
|
1
|
999
|
8
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
megamutts
|
1.5K |
649K |
15 |
19/09/22 |
19/09/22 |
ASX - By Stock
|
1.5K
|
649K
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
megamutts
|
382 |
194K |
0 |
18/09/22 |
18/09/22 |
ASX - By Stock
|
382
|
194K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Clinical Development Update for Eftilagimod Alpha
|
|
megamutts
|
12 |
5.8K |
13 |
14/09/22 |
14/09/22 |
ASX - By Stock
|
12
|
5.8K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Appoints LAG-3 Pioneer Dr Frederic Triebel to Board
|
|
megamutts
|
35 |
11K |
9 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
35
|
11K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Acadia submits Rett Syndrome New Drug Application to the FDA
|
|
megamutts
|
95 |
48K |
26 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
95
|
48K
|
26
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
6 |
08/09/22 |
08/09/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
megamutts
|
2.7K |
1.1M |
2 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
2.7K
|
1.1M
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: New investigator-initiated ph2 trial in Soft Tissue Sarcoma
|
|
megamutts
|
9 |
3.7K |
6 |
06/09/22 |
06/09/22 |
ASX - By Stock
|
9
|
3.7K
|
6
|
|